Business Wire

NanoString Launches New nCounter Pro Analysis System

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of ...
Business Wire

NanoString Launches nCounter TCR Diversity Panel and Analysis Package at the 2021 Annual Meeting of the Society for Immunotherapy of Cancer

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
Nasdaq

NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
ascopubs.org

Colorectal cancer gene expression profiling using nanostring nCounter analysis.

Regular statin users and colorectal cancer (CRC) prognosis. Neoadjuvant chemoradiotherapy (NCRT) using concurrent S-1 and irinotecan in rectal cancer: Impact on long-term clinical outcomes and ...
ascopubs.org

Gene expression profiling of anaplastic thyroid carcinoma and coexisting differentiated thyroid carcinoma using the NanoString nCounter system.

A comparison of the burden of thyroid cancer amongst European Union 15+ countries, 1990-2017: Estimates from the Global Burden of Disease Study. This is an ASCO Meeting Abstract from the 2021 ASCO ...